Tradjenta is classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor that is used with diet and exercise to lower blood sugar levels in adults withtype 2 diabetes. The generic name for Tradjenta is Linagliptin. Fact Table Formula C25H26N8O2 License US FDA, EU EMA, US DailyMed Bioavailability ~30% Legal status Rx-Only Chemical Name Linagliptin Elimination half-life ~24 hours Dosage (Strength) 5mg Pregnancy Not recommended Brands Tradjenta Protein binding 75–99% PubChem CID 10096344 MedlinePlus a611036 ChEBI 68610 ATC code A10BH05 DrugBank DB08882 KEGG D09566 Routes of administration By mouth
Tradjenta (Linagliptin)
- Tradjenta is available as a 5 mg oral tablet. The dose of Tradjenta is 5 mg by mouth once daily with or without food.
